Skip to content
2000
Volume 14, Issue 1
  • ISSN: 1573-4064
  • E-ISSN: 1875-6638

Abstract

Background: Acute myeloid leukemia (AML) is the most common hematological malignancy in adults, characterized by distorted proliferation and development of myeloid cells and their precursors in the bone marrow. Nitidine chloride, a naturally occurring alkaloid, has been identified to possess antitumor activity. However, the effects of nitidine chloride on acute myeloid leukemia cells and its underlying mechanisms have not been elucidated. Here we investigated the cellular and molecular mechanism of the anti-leukemic effects of nitidine chloride. Methods and Results: Nitidine chloride treatment for 48 consecutive hours exhibited a timedependent and dose-dependent growth inhibition activity against AML cells by inducing cell cycle arrest and apoptosis. Moreover, nitidine chloride downregulated Cyclin B1, CDK1 and Bcl-2, upregulated p27 and Bax, inactivated PARP, activated Caspase-3 in AML cells. We further demonstrated that growth inhibition activity of nitidine chloride in AML cells is partially via inhibiting the phosphorylation of AKT and ERK. Conclusion: In conclusion, our data suggest that nitidine chloride could be an effective therapeutic agent against AML via cell cycle arrest and apoptosis.

Loading

Article metrics loading...

/content/journals/mc/10.2174/1573406413666170620091543
2018-02-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/mc/10.2174/1573406413666170620091543
Loading

  • Article Type:
    Research Article
Keyword(s): acute myeloid leukemia; AKT; apoptosis; cell cycle; ERK; nitidine chloride
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test